company background image
0DHC logo

Carl Zeiss Meditec LSE:0DHC Stock Report

Last Price

€102.10

Market Cap

€9.1b

7D

-1.7%

1Y

-12.9%

Updated

17 Apr, 2024

Data

Company Financials +

0DHC Stock Overview

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia.

0DHC fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance2/6
Financial Health5/6
Dividends0/6

Carl Zeiss Meditec AG Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Carl Zeiss Meditec
Historical stock prices
Current Share Price€102.10
52 Week High€126.05
52 Week Low€72.80
Beta0.90
1 Month Change-14.93%
3 Month Change-0.28%
1 Year Change-12.86%
3 Year Change-28.98%
5 Year Change22.28%
Change since IPO923.30%

Recent News & Updates

Recent updates

Shareholder Returns

0DHCGB Medical EquipmentGB Market
7D-1.7%-1.7%0.4%
1Y-12.9%-6.5%-1.0%

Return vs Industry: 0DHC underperformed the UK Medical Equipment industry which returned -6.5% over the past year.

Return vs Market: 0DHC underperformed the UK Market which returned -1% over the past year.

Price Volatility

Is 0DHC's price volatile compared to industry and market?
0DHC volatility
0DHC Average Weekly Movement3.9%
Medical Equipment Industry Average Movement8.0%
Market Average Movement4.9%
10% most volatile stocks in GB Market11.3%
10% least volatile stocks in GB Market2.6%

Stable Share Price: 0DHC has not had significant price volatility in the past 3 months.

Volatility Over Time: 0DHC's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
18464,823Markus Weberwww.zeiss.com/meditec-ag/de/investor-relations.html?vaURL=www.zeiss.de/meditec-ag/ir

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, North America, and Asia. It operates in two segments, Ophthalmology and Microsurgery. The Ophthalmology segment offers products and solutions for the diagnosis and treatment of chronic eye diseases, such as ametropia (refraction), cataracts, glaucoma, and renital disorders.

Carl Zeiss Meditec AG Fundamentals Summary

How do Carl Zeiss Meditec's earnings and revenue compare to its market cap?
0DHC fundamental statistics
Market cap€9.12b
Earnings (TTM)€276.80m
Revenue (TTM)€2.09b

33.0x

P/E Ratio

4.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0DHC income statement (TTM)
Revenue€2.09b
Cost of Revenue€893.14m
Gross Profit€1.20b
Other Expenses€924.07m
Earnings€276.80m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

May 08, 2024

Earnings per share (EPS)3.09
Gross Margin57.35%
Net Profit Margin13.22%
Debt/Equity Ratio7.2%

How did 0DHC perform over the long term?

See historical performance and comparison

Dividends

1.1%

Current Dividend Yield

36%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.